Yap Kim Choy
SEC insider (Form 3/4/5 filer). CIK 0002081554. 10% Owner at Cyclacel Pharmaceuticals, Inc. (CYCC). 8 reported Form 4/5 transactions since Sep 2024; latest on Nov 5, 2025. Located in PUCHONG, N8.
Companies Yap Kim Choy has filed insider reports for
- Cyclacel Pharmaceuticals, Inc. (CYCC): 10% Owner
Yap Kim Choy
CIK: 0002081554
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cyclacel Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Nov 5, 2025BGMS
Bio Green Med Solution, Inc.
OtherDirect467.5K shares- - Nov 5, 2025BGMS
Bio Green Med Solution, Inc.
SaleDirect28.5K shares at avg. $1.70$49K - Oct 30, 2025BGMS
Bio Green Med Solution, Inc.
SaleDirect112.3K shares at avg. $1.81$203K - Oct 29, 2025BGMS
Bio Green Med Solution, Inc.
SaleDirect110.7K shares at avg. $1.83$203K - Oct 28, 2025BGMS
Bio Green Med Solution, Inc.
SaleDirect13.1K shares at avg. $1.83$24K - Oct 27, 2025BGMS
Bio Green Med Solution, Inc.
SaleDirect120.3K shares at avg. $2.12$255K - Oct 24, 2025BGMS
Bio Green Med Solution, Inc.
SaleDirect19.6K shares at avg. $1.90$37K - Sep 4, 2025CYCC
Cyclacel Pharmaceuticals, Inc.
OtherDirect186.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 5, 2025 | BGMS Bio Green Med Solution, Inc. | Other | 467,535 | - | - | Direct |
| Nov 5, 2025 | BGMS Bio Green Med Solution, Inc. | Sale | 28,540 | $1.70 | $48,518 | Direct |
| Oct 30, 2025 | BGMS Bio Green Med Solution, Inc. | Sale | 112,260 | $1.81 | $202,854 | Direct |
| Oct 29, 2025 | BGMS Bio Green Med Solution, Inc. | Sale | 110,749 | $1.83 | $203,114 | Direct |
| Oct 28, 2025 | BGMS Bio Green Med Solution, Inc. | Sale | 13,111 | $1.83 | $23,967 | Direct |
| Oct 27, 2025 | BGMS Bio Green Med Solution, Inc. | Sale | 120,250 | $2.12 | $254,690 | Direct |
| Oct 24, 2025 | BGMS Bio Green Med Solution, Inc. | Sale | 19,595 | $1.90 | $37,270 | Direct |
| Sep 4, 2025 | CYCC Cyclacel Pharmaceuticals, Inc. | Other | 186,465 | - | - | Direct |
1-8 of 8 transactions